Fospropofol: Clinical pharmacology

Journal of Anaesthesiology Clinical Pharmacology

Volumn 27, Issue 1, 2011, Pages 79-83

  Bengalorkar, Girish M ^a   Bhuvana, K ^a   Sarala, N ^a   Kumar, T N ^a  

^a SRI DEVARAJ URS MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; FOSPROPOFOL; MIDAZOLAM; PROPOFOL;

APNEA; ARTICLE; BRADYCARDIA; CLINICAL PHARMACOLOGY; CONSCIOUSNESS DISORDER; CONVULSION; COUGHING; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG DISTRIBUTION; DRUG DOSAGE FORM COMPARISON; DRUG ELIMINATION; DRUG FORMULATION; DRUG INDICATION; DRUG MECHANISM; DRUG METABOLISM; DRUG STRUCTURE; HUMAN; HYPOTENSION; HYPOXIA; INJECTION SITE PAIN; NAUSEA AND VOMITING; PARESTHESIA; PRURITUS; REPEATED DRUG DOSE; RESPIRATION DEPRESSION; SEDATION;

EID: 79951901338     PISSN: 09709185     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Garnock-Jones KP, Scott LJ. Fospropofol. Drugs 2010; 70 (4): 469-477.
2. Fanti L, Testoni PA. Sedation and analgesia in gastrointestinal endoscopy: What's new? World J Gastroenterol 2010; 16(20): 2451-2457
3. Mueller SW, Moore GD, MacLaren R. Fospropofol Disodium for Procedural Sedation: Emerging Evidence of its Value? Clinical Medicine Insights: Therapeutics 2010; 2: 513-522.
4. Welliver M, Rugari SM. New drug, fospropofol disodium: a propofol prodrug. AANA J. 2009;77(4): 301-308.
5. Fospropofol Disodium Injection NDA 22-244, MGI PHARMA, Inc. Briefing materials for the anaesthetic and life support drugs advisory committee to the division of anaesthesia, analgesia, and rheumatology products (DAARP)/CDER/FDA. May 7, 2008 Available from URL:http:www.fda.gov/ohrms/dockets/ac/08/briefing/2008-4354b1-02-MGI.pdf. [Accessed 2010 Aug 17].
6. Grasshoff C, Gilless T. Effects of propofol on N -methyl-D-aspartate receptor-mediated calcium increase in cultured rat cerebrocortical neurons. Eur J Anaesthesiol 2005; 22(6):467-470.
7. Eisai I. Lusedra_ (fospropofol disodium) US prescribing information [online]. Available from URL: http:// www.eisai.com/package_inserts/Lusedra%20PI.pdf [Accessed 2010 Aug 17]
8. Schywalsky M, Ihmsen H, Tzabazis A, Fechner J, Burak E, Vornov J, et al. Pharmacokinetics and pharmacodynamics of the new propofol prodrug GPI 15715 in rats. Eur J Anaesthesiol 2003;20(3):182-190.
9. Dharshwar SS, Stella VJ. Your prodrug releases formaldehyde: should you be concerned? No! J Pharm Sci 2008;97(10):4184-4193.
10. Fechner J, Ihmsen H, Hatterschild D, Jeleazcov C, Schiessl C, Vornov JJ, et al. Comparative pharmacokinetics and pharmacodynamics of the new propofol prodrug GPI 15715 and propofol emulsion. Anesthesiology 2004; 101(3): 626-639.
11. Gan TJ, Berry BD, Ekman EF, Muckerman RC, Shore N, Hardi R. Safety evaluation of fospropofol for sedation during minor surgical procedures. J Clin Anesth 2010; 22(4): 260-267.
12. Neff SPW, Stapelberg GF, Warmington A. Excruciating perineal pain after intravenous dexamethasone. Anaesth Intensive Care 2002; 30(3): 370-371.
13. Hudes G, Haas N, Yeslow G, Gillon T, Gunnarsson PO, Ellmanet M. Phase I clinical and pharmacologic trial of intravenous estramustine phosphate. J Clin Oncol 2002; 20(4): 1115-1127.
14. Levitzky BE, Vargo JJ. Fospropofol disodium injection for the sedation of patients undergoing colonoscopy. Ther Clin Risk Manag 2008; 4 (4): 733-738.
15. Gibiansky E, Struys MMRF, Gibiansky L, Vanluchene AL, Vornov J, Mortier EP, et al. AQUAVAN injection, a water-soluble prodrug of propofol, as a bolus injection: a phase I dose-escalation comparison with DIPRIVAN, part 1: pharmacokinetics [published correction appears in Anesthesiology. 2008; 109(5): 940]. Anesthesiology 2005; 103(4): 718-729.
16. Sweetman SC. Martindale: The Complete Drug Reference. 36th ed, Pharmaceutical Press London; 2009: p1791-1793.
17. Gan TJ. Pharmacokinetic and pharmacodynamic characteristics of medications used for moderate sedation. Clin Pharmacokinet 2006; 45 (9): 855-869.
18. Harris HA, Lubarsky DA, Candiotti KA. Monitored anesthesia care. Ther Clin Risk Manag 2009; 5: 949-959.
19. Cohen LB. Clinical trial: a dose-response study of fospropofol disodium for moderate sedation during colonoscopy. Aliment Pharmacol Ther 2008; 27 (7): 597-608.
20. Silvestri GA, Vincent BD, Wahidi MM, Robinette E, Hansbrough JR, Downie GH, et al. A phase 3, randomized, double-blind study to assess the efficacy and safety of fospropofol disodium injection for moderate sedation in patients undergoing flexible bronchoscopy. Chest 2009;135 (1): 41-47.
21. Cohen LB, Cattau E, Goetsch A, Shah A, Weber JR, Rex DK, et al. A randomized, double-blind, phase 3 study of fospropofol disodium for sedation during colonoscopy. J Clin Gastroenterol 2010; 44(5): 345-353.
22. Lusedra (Fospropofol Disodium) for minimal to moderate sedation for regional anesthesia block prior to orthopedic surgery [ClinicalTrials.gov identifier NCT01195103]. US National Institutes of Health, ClinicalTrials.gov [online]. Available from URL:http:www//clinicaltrials.gov/show/NCT01195103 [Accessed 2010 Aug 17].
23. Fechner J, Ihmsen H, Jeleazcov C, Schüttler J. Fospropofol disodium, a water-soluble prodrug of the intravenous anesthetic propofol (2,6-diisopropylphenol). Expert Opin Investig Drugs 2009 18(10):1565-1571.
24. GPI 15715 For sedation in the Intensive Care Unit (ICU) setting [ClinicalTrials.gov identifier NCT00125398]. US National Institutes of Health, ClinicalTrials.gov [online]. Available from URL:http://clinicaltrials.gov/show/NCT00125398 [Accessed 2010 Aug 17]
25. Comparison of AQUAVAN injection to DISOPRIVAN injectable emulsion for anesthesia during coronary artery surgery [ClinicalTrials.gov identifier NCT00209521]. US National Institutes of Health, ClinicalTrials.gov [online]. Available from url:http://clinicaltrials.gov/show/NCT00209521 [Accessed 2010 Aug 17]
26. Study to assess safety and efficacy of AQUAVAN injection for sedation during cardiac catheterization [ClinicalTrials.gov identifier NCT00209547]. US National Institutes of Health, ClinicalTrials.gov [online]. Available from URL:http://clinicaltrials.gov/show/NCT00209547 [Accessed 2010 Aug 17] J Anaesth Clin Pharmacol 2011; 27(1): 79-83